Your browser doesn't support javascript.
loading
Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia.
Blood ; 119(12): 2854-62, 2012 Mar 22.
Article in En | MEDLINE | ID: mdl-22308293

Full text: 1 Database: MEDLINE Main subject: Vidarabine / Leukemia, Lymphocytic, Chronic, B-Cell / Tumor Suppressor Protein p53 / Drug Resistance, Neoplasm / Inhibitor of Apoptosis Proteins / Antineoplastic Agents Type of study: Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Year: 2012 Type: Article

Full text: 1 Database: MEDLINE Main subject: Vidarabine / Leukemia, Lymphocytic, Chronic, B-Cell / Tumor Suppressor Protein p53 / Drug Resistance, Neoplasm / Inhibitor of Apoptosis Proteins / Antineoplastic Agents Type of study: Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Year: 2012 Type: Article